| Company Name | Date | Purpose |
|---|---|---|
| Star Health Insu | 28-Jan-2026 | Star Health And Allied Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 inter alia to consider and approve the unaudited financial results for the quarter and nine months ended December 2025. |
| Wherrelz IT | 28-Jan-2026 | Preferential Issue of shares & Issue Of Warrants Inter alia to consider and approve the following: - 1. Preferential Issue of shares and/or warrants as per Chapter V and in accordance with Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 to non-promoters for cash consideration (conversion of Loan) subject to approval of shareholders and such other approvals as may be required under applicable laws; 2. To fix relevant date for the purpose of preferential issue; 3. To fix, day, date and time for Extra Ordinary General Meeting and to appoint scrutinizer. 4. Any other business with the permission of Chairman. Postponement of Board meeting (As per BSE announcement dated on : 22.01.2026) Wherrelz IT Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve 1. Preferential Issue of shares and/or warrants as per Chapter V and in accordance with Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 to non-promoters for cash consideration (conversion of Loan) subject to approval of shareholders and such other approvals as may be required under applicable laws;; 2. To fix relevant date for the purpose of preferential issue; 3. To fix, day, date and time for Extra Ordinary General Meeting and to appoint scrutinizer. 4. Any other business with the permission of Chairman. (As per BSE Announcement dated on: 24.01.2026) |
| Rainbow Child. | 28-Jan-2026 | Quarterly Results Rainbow Children''s Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Nine months Ended December 31, 2025. |
| Prudent Corp. | 28-Jan-2026 | Prudent Corporate Advisory Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 inter alia to consider and approve Unaudited Financial Results for the quarter and nine months ended December 31 2025. |
| Piramal Pharma | 28-Jan-2026 | Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve the Un audited Financial Results (Standalone and Consolidated) of the Company for quarter and nine months ended 31st December, 2025. |
| Five-Star Bus.Fi | 28-Jan-2026 | Five-Star Business Finance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 inter alia to consider and approve Unaudited Financial results for the quarter and nine months ended December 31 2025 |
| Macfos | 28-Jan-2026 | Quarterly Results & Bonus issue Macfos Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 28th Day of January 2026, at the registered office of the Company, inter alia. 1. To consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December, 2025, and the Auditor''s limited review report thereon. 2. To consider and approve the proposal for the issue of Bonus shares, subject to requisite approvals. As informed vide Company''s intimation letter dated 29th, December 2025, the Trading Window for dealing in the Securities of the Company is closed from 01st January 2026 and shall re-open after 48 hours from the declaration of Financial Results. |
| Sudarshan Pharma | 28-Jan-2026 | Quarterly Results Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 31/December/2025. (As Per BSE Announcement Dated on 22.01.2026) |
| NIIT Learning | 28-Jan-2026 | Quarterly Results NIIT Learning Systems Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors ('the Board') of the Company is scheduled to be held on Wednesday, January 28, 2026, inter-alia, to consider and approve, Unaudited Financial Results for the quarter and nine months ended December 31, 2025, both Consolidated and Standalone. |
| Aeroflex | 28-Jan-2026 | Quarterly Results Aeroflex Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve 1. Un-audited Standalone and Consolidated Financial Results for the quarter ended December 31, 2025 and Limited Review Reports thereon. 2. Any other business with the permission of the Chair. |